Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals, therefore it is important to identify mitochondrial toxicity during the early stages of the drug discovery process.
New in vitro strategies are being introduced to the market, which are more specific and sensitive.Download this infographic to learn about:
- The impact of mitochondrial toxicity in drug discovery
- The benefits of novel in vitro strategies for drug safety
- New in vitro products on the market